GlaxoSmithKline Pharmaceuticals Limited has announced the results of its postal ballot process concerning two ordinary resolutions. The first resolution was for the appointment of Mr. Ronojit Biswas (DIN 07684843) as a Director. The second resolution was for his appointment as a Whole-time Director & Chief Financial Officer (CFO). The postal ballot process, which included remote e-voting, commenced on Monday, March 9, 2026, at 09:00 a.m. and concluded on Wednesday, April 8, 2026, at 05:00 p.m. Based on the scrutinizer's report, both resolutions were passed on the last day of e-voting, April 8, 2026. For the appointment of Mr. Ronojit Biswas as a Director, 99.69% of the valid votes cast were in favour, with 690 members casting valid votes totaling 14,19,31,591 shares. 0.31% of the votes were against. For the appointment of Mr. Ronojit Biswas as Whole-time Director & CFO, 99.76% of the valid votes cast were in favour, with 694 members casting valid votes totaling 14,20,26,635 shares. 0.24% of the votes were against. The voting results and the scrutinizer's report are available on the company's website and the e-voting platform.
